Erol R. Akdamar - 01 Jan 2023 Form 3 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
01 Jan 2023
Transactions value $
$0
Form type
3
Filing time
11 Jan 2023, 17:42:19 UTC
Next filing
01 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCA Common Stock 37.7K 01 Jan 2023 Direct
holding HCA Common Stock 60K 01 Jan 2023 By LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 9K $45.30 Direct F1
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 14.5K $47.97 Direct F2
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 12.3K $47.97 Direct F3
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 20K $68.96 Direct F4
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 16.4K $69.58 Direct F5
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 17.4K $81.96 Direct F6
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 25.2K $101.16 Direct F7
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 14.7K $139.06 Direct F8
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 16.9K $145.24 Direct F9
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 12.8K $173.12 Direct F10
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 8.49K $236.61 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on November 6, 2014.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
F3 The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.
F4 The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
F5 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
F6 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
F7 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
F8 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020.
F9 The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021.
F10 The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022.
F11 The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.